Utilize este identificador para referenciar este registo: https://hdl.handle.net/10316/113691
Campo DCValorIdioma
dc.contributor.authorBarbosa, Pedro-
dc.contributor.authorCarvalho, Eugenia-
dc.date.accessioned2024-02-27T10:54:51Z-
dc.date.available2024-02-27T10:54:51Z-
dc.date.issued2023-
dc.identifier.issn2673-4540pt
dc.identifier.urihttps://hdl.handle.net/10316/113691-
dc.description.abstractGlucose, fructose, and galactose are widely used in the food industry as sweeteners and food additives. The over-consumption of these carbohydrates has been identified as a possible trigger of non-communicable diseases. These include insulin resistance, obesity, and type 2 diabetes. These sugars induce an energy overload with consequent adipose tissue (AT) expansion, contributing to the development of obesity. Furthermore, a common feature of these non-communicable diseases is the detrimental, chronic, low-grade inflammation contributing to their onset. In the present review, we identify the most widely used dietary free sugars and their direct impacts on AT metabolism and inflammation, as well as their involvement in systemic inflammation and effects on the immune cell phenotype and function. Additionally, we discuss the capacity of the free sugars to induce immune modulation, enhancing inflammation, an underlying hallmark of insulin resistance, obesity, and T2DM. Dietary sugars have an important and deleterious metabolic impact on AT and also on immune cells. More research is needed to effectively understand the impact of chronic exposure to high levels of individual or combined sugars on metabolism, with the impact on immunomodulation being especially important.pt
dc.language.isoengpt
dc.publisherMDPIpt
dc.relationCENTRO-01- 0145-FEDER-000012pt
dc.relationPOCI-01-0145-FEDER-007440pt
dc.relationUIDB/04539/2020pt
dc.relationinfo:eu-repo/grantAgreement/UIDP/04539/2020pt
dc.relationLA/P/0058/2020pt
dc.relationSFRH/BD/143849/2019pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectimmunomodulationpt
dc.subjectinflammationpt
dc.subjectinsulin resistancept
dc.subjectsugar metabolismpt
dc.subjectadipose tissuept
dc.titleAre Dietary Sugars Potent Adipose Tissue and Immune Cell Modulators?pt
dc.typearticle-
degois.publication.firstPage30pt
degois.publication.lastPage45pt
degois.publication.issue1pt
degois.publication.titleDiabetologypt
dc.peerreviewedyespt
dc.identifier.doi10.3390/diabetology4010005pt
degois.publication.volume4pt
dc.date.embargo2023-01-01*
uc.date.periodoEmbargo0pt
item.fulltextCom Texto completo-
item.grantfulltextopen-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.project.grantnoCenter for Innovative Biomedicine and Biotechnology - CIBB-
crisitem.project.grantnoCenter for Innovative Biomedicine and Biotechnology-
crisitem.project.grantnoCenter for Innovative Biomedicine and Biotechnology - Associate Laboratory-
crisitem.author.orcid0000-0001-6264-3632-
Aparece nas coleções:I&D CNC - Artigos em Revistas Internacionais
IIIUC - Artigos em Revistas Internacionais
Ficheiros deste registo:
Mostrar registo em formato simples

Visualizações de página

60
Visto em 25/set/2024

Downloads

39
Visto em 25/set/2024

Google ScholarTM

Verificar

Altmetric

Altmetric


Este registo está protegido por Licença Creative Commons Creative Commons